Milestone Scientific (MLSS) Competitors

Delcath Systems (NASDAQ:DCTH) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, community ranking, dividends and valuation.

Which has more risk & volatility, DCTH or MLSS?

Delcath Systems has a beta of 0.78, suggesting that its share price is 22% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.

Do analysts prefer DCTH or MLSS?

Delcath Systems currently has a consensus price target of $21.67, suggesting a potential upside of 128.07%. Given Delcath Systems' higher possible upside, research analysts clearly believe Delcath Systems is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has higher earnings & valuation, DCTH or MLSS?

Milestone Scientific has lower revenue, but higher earnings than Delcath Systems. Milestone Scientific is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$11.88M	22.22	-$47.68M	-$2.65	-3.58
Milestone Scientific	$8.42M	8.53	-$6.93M	-$0.10	-9.30

Do institutionals and insiders believe in DCTH or MLSS?

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 17.9% of Delcath Systems shares are held by company insiders. Comparatively, 24.8% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer DCTH or MLSS?

Delcath Systems received 26 more outperform votes than Milestone Scientific when rated by MarketBeat users. Likewise, 23.85% of users gave Delcath Systems an outperform vote while only 0.00% of users gave Milestone Scientific an outperform vote.

Company	Underperform	Outperform
Delcath Systems	Outperform Votes 26 23.85%	Underperform Votes 83 76.15%
Milestone Scientific	Outperform Votes No Votes	Underperform Votes 64 100.00%

Does the media refer more to DCTH or MLSS?

In the previous week, Delcath Systems had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Delcath Systems and 2 mentions for Milestone Scientific. Delcath Systems' average media sentiment score of 1.23 beat Milestone Scientific's score of 0.30 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Milestone Scientific	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is DCTH or MLSS more profitable?

Milestone Scientific has a net margin of -54.87% compared to Delcath Systems' net margin of -474.22%. Milestone Scientific's return on equity of -60.78% beat Delcath Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	-474.22%	-312.48%	-118.65%
Milestone Scientific	-54.87%	-60.78%	-40.80%

Summary

Delcath Systems beats Milestone Scientific on 10 of the 17 factors compared between the two stocks.